Notícias 4D Molecular Therapeutics Inc - FDMT | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
4D Molecular Therapeutics Inc (FDMT)
4D Molecular Therapeutics Inc (FDMT) Notícias

4D Molecular Therapeutics Inc (FDMT)

8,74

-0,09

( -1,02% )

Atualizado: 13:06:31

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day

4DMT Announces Presentations at Upcoming Retina Conferences

4DMT to Participate in the 2024 Cantor Global Healthcare Conference

4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

4D Molecular Therapeutics

Smurfit WestRock

Canadian Palladium Resou...

Invesco Senior Income

Seasif Exploration

PTC Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições